Yong Yu
Soochow University (Suzhou)
7 Papers
39 Citations
Yong Yu is an academic researcher from Soochow University (Suzhou). The author has contributed to research in topics: Pleiotrophin & Cell. The author has an hindex of 4, co-authored 7 publications.
Chat about Author
Papers
Serum pleiotrophin could be an early indicator for diagnosis and prognosis of non-small cell lung cancer.
TL;DR: The study suggests that the serum PTN level of patients with NSCLC could be an early indicator for diagnosis and prognosis, and should be further assessed in randomized clinical trials.
Non-platinum regimens of gemcitabine plus docetaxel versus platinum-based regimens in first-line treatment of advanced non-small cell lung cancer: a meta-analysis on 9 randomized controlled trials
TL;DR: GD acquired similar survival with platinum-based regimens in first-line treatment of advanced NSCLC and had an advantage in TTP and ORR with more grade 3–4 nausea/vomiting, anemia, neutropenia and febrile neutropania compared with GD.
16
A Phase 1 randomized study compare the pharmacokinetics, safety and immunogenicity of HLX02 to reference CN- and EU-sourced trastuzumab in healthy subjects
Xiaoxue Zhu,Yi-hong Ding,Yong Yu,Meng Wang,W Zhou,Jing Wang,Haibo Zhang,Katherine Chai,Xu-Chao Zhang,A Luk,Wen Qi Jiang,S Liu,Qi Zhang +12 more
TL;DR: Equivalence was concluded if the 90% confidence interval (CI) for the geometric least squares mean ratio (GLSMR) fell in the equivalence criteria of 0.80–1.25 and secondary endpoints comparisons also fell in this criteria.
15
•Journal Article
Bacterial contamination of medical uniforms: a cross-sectional study from Suzhou city, China.
TL;DR: It is demonstrated that medical uniforms can harbour microorganisms and proper handling of medical uniforms and adequate education to medical staffs are required to decrease healthcare-associated infections.
5
Construction of siRNA lentiviral expressing vector targeting pleiotrophin gene and its impact on growth and apoptosis in H446 cells of human small cell lung cancer
TL;DR: PTN RNAi vector construction and H446 cell transfection effectively reduced the PTN transcription and expression, inhibited the growth and promoted the apoptosis of tumor cells, and this method may become a useful therapeutic strategy for small cell lung cancer overexpressing PTN.
2